Alliance Global raised the firm’s price target on Curaleaf (CURLF) to C$6 from C$5 and keeps a Buy rating on the shares after having hosted a fireside chat with CEO Boris Jordan and Chief Investment Officer Camilo Lyon following the signing of the executive order last Thursday by President Donald Trump that directed the Department of Justice to reclassify cannabis. The firm is “encouraged” by the prospects for Curaleaf to capitalize on the incremental growth opportunities post rescheduling, the analyst tells investors after the management meeting.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CURLF:
- EO rescheduling seen as buying opportunity for cannabis stocks, says ATB Capital
- Curaleaf Walks Away From Cannabist’s Virginia Deal, Citing Valuation Concerns
- Curaleaf reports termination of equity purchase agreement with The Cannabist Co.
- Cannabist to sell Virginia assets to Millstreet for $130M, cancels Curaleaf deal
- Curaleaf ‘applauds’ Trump Administration’s rescheduling of cannabis